Roche Holding AG's Fiscal Year is From January To December.
The item "Ebitda-Interest-Coverage" stands at 5.49 as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.
As of the end of Roche Holding AG's second quarter, the item "Ebitda Interest Coverage" stands at 5.49. This represents a decrease of -23.69 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -49.31 percent compared to the value the year prior.
The 1 year change in percent is -49.31.
The 3 year change in percent is -85.84.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Ebitda Interest Coverage | 905,699,262,464.00 |
![]() | Johnson & Johnson - Ebitda Interest Coverage | 486,508,953,600.00 |
![]() | AbbVie Inc - Ebitda Interest Coverage | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Ebitda Interest Coverage | 280,205,508,085.11 |
![]() | Novartis AG - Ebitda Interest Coverage | 255,096,620,580.91 |